1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine

C23H22BrF3N2O4 — CID 118906106

IUPAC1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine
SMILESCOc1cc(-c2nc(Br)c3n2CC(COCc2ccccc2)OCC3)ccc1OC(F)(F)F
InChIInChI=1S/C23H22BrF3N2O4/c1-30-20-11-16(7-8-19(20)33-23(25,26)27)22-28-21(24)18-9-10-32-17(12-29(18)22)14-31-13-15-5-3-2-4-6-15/h2-8,11,17H,9-10,12-14H2,1H3
InChIKeyAPNGOBYDWIXFOZ-UHFFFAOYSA-N
MW527.34 g/mol
LogP5.38
Rot. Bonds7

About 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine

1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine (PubChem CID 118906106) has the molecular formula C23H22BrF3N2O4 and a molecular weight of 527.34 g/mol. Its IUPAC name is 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine.

Molecular Properties

Compound Name1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine
PubChem CID118906106
Molecular FormulaC23H22BrF3N2O4
Molecular Weight527.34 g/mol
Exact Mass526.07
IUPAC Name1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine
SMILESCOc1cc(-c2nc(Br)c3n2CC(COCc2ccccc2)OCC3)ccc1OC(F)(F)F
InChIInChI=1S/C23H22BrF3N2O4/c1-30-20-11-16(7-8-19(20)33-23(25,26)27)22-28-21(24)18-9-10-32-17(12-29(18)22)14-31-13-15-5-3-2-4-6-15/h2-8,11,17H,9-10,12-14H2,1H3
InChIKeyAPNGOBYDWIXFOZ-UHFFFAOYSA-N
XLogP5.38
TPSA54.74 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms33
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500527.34
LogP ≤ 55.38
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine?
The IUPAC name of 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine (CID 118906106) is 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine.
What is the SMILES notation for 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine?
The canonical SMILES for 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine is COc1cc(-c2nc(Br)c3n2CC(COCc2ccccc2)OCC3)ccc1OC(F)(F)F.
What is the InChIKey of 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine?
The InChIKey is APNGOBYDWIXFOZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H22BrF3N2O4/c1-30-20-11-16(7-8-19(20)33-23(25,26)27)22-28-21(24)18-9-10-32-17(12-29(18)22)14-31-13-15-5-3-2-4-6-15/h2-8,11,17H,9-10,12-14H2,1H3.
What are the key properties of 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine?
1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine has a molecular weight of 527.34 g/mol, XLogP of 5.38, 7 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 1-bromo-3-[3-methoxy-4-(trifluoromethoxy)phenyl]-6-(phenylmethoxymethyl)-5,6,8,9-tetrahydroimidazo[1,5-d][1,4]oxazepine is sourced from PubChem (CID 118906106), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).